R. McGory

1.0k total citations
14 papers, 783 citations indexed

About

R. McGory is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, R. McGory has authored 14 papers receiving a total of 783 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 8 papers in Hepatology and 6 papers in Surgery. Recurrent topics in R. McGory's work include Hepatitis B Virus Studies (8 papers), Renal Transplantation Outcomes and Treatments (6 papers) and Hepatitis C virus research (6 papers). R. McGory is often cited by papers focused on Hepatitis B Virus Studies (8 papers), Renal Transplantation Outcomes and Treatments (6 papers) and Hepatitis C virus research (6 papers). R. McGory collaborates with scholars based in United States and Switzerland. R. McGory's co-authors include Gary R. Matzke, C E Halstenson, W. F. Keane, Timothy L. Pruett, Stephen H. Caldwell, William Stevenson, Michael B. Ishitani, Walter Oliveira, Christopher S. McCullough and Rolland C. Dickson and has published in prestigious journals such as Gastroenterology, Annals of Surgery and Antimicrobial Agents and Chemotherapy.

In The Last Decade

R. McGory

14 papers receiving 756 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. McGory United States 10 482 391 254 196 116 14 783
Manuel Crespo Spain 15 264 0.5× 260 0.7× 207 0.8× 118 0.6× 26 0.2× 47 776
Edmund Tse Australia 11 335 0.7× 319 0.8× 217 0.9× 161 0.8× 35 0.3× 37 623
Marilyn M. Wagener United States 9 336 0.7× 161 0.4× 146 0.6× 34 0.2× 128 1.1× 9 545
Oskar Janata Austria 8 222 0.5× 152 0.4× 147 0.6× 26 0.1× 102 0.9× 14 453
Qiquan Wan China 15 272 0.6× 51 0.1× 85 0.3× 116 0.6× 122 1.1× 56 615
Peter Nicholas United States 13 384 0.8× 99 0.3× 319 1.3× 52 0.3× 241 2.1× 21 768
R J Wyke United Kingdom 15 406 0.8× 425 1.1× 131 0.5× 9 0.0× 192 1.7× 27 816
Anders Lannergård Sweden 10 221 0.5× 80 0.2× 60 0.2× 31 0.2× 43 0.4× 18 363
Cheryl Wannstedt United States 13 540 1.1× 362 0.9× 102 0.4× 19 0.1× 117 1.0× 16 699
J. P. Richardet France 9 340 0.7× 308 0.8× 136 0.5× 13 0.1× 75 0.6× 14 529

Countries citing papers authored by R. McGory

Since Specialization
Citations

This map shows the geographic impact of R. McGory's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. McGory with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. McGory more than expected).

Fields of papers citing papers by R. McGory

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. McGory. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. McGory. The network helps show where R. McGory may publish in the future.

Co-authorship network of co-authors of R. McGory

This figure shows the co-authorship network connecting the top 25 collaborators of R. McGory. A scholar is included among the top collaborators of R. McGory based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. McGory. R. McGory is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Pruett, T., R. McGory, Francis H. Wright, et al.. (2009). Safety Profile, Pharmacokinetics, and Pharmacodynamics of Siplizumab, A Humanized Anti-CD2 Monoclonal Antibody, in Renal Allograft Recipients. Transplantation Proceedings. 41(9). 3655–3661. 14 indexed citations
2.
McGory, R., et al.. (2000). Hepatitis B immune globulin: the US experience.. PubMed. 14 Suppl 2. 7–13. 13 indexed citations
3.
McGory, R.. (2000). Pharmacoeconomic analysis of HBV liver transplant therapies.. PubMed. 14 Suppl 2. 29–38. 16 indexed citations
4.
Sawyer, Robert G., R. McGory, M. J. Gaffey, et al.. (1998). Improved Clinical Outcomes With Liver Transplantation for Hepatitis B-Induced Chronic Liver Failure Using Passive Immunization. Annals of Surgery. 227(6). 841–850. 102 indexed citations
5.
Pruett, T., et al.. (1998). ORAL GANCICLOVIR DOSING IN TRANSPLANT RECIPIENTS AND DIALYSIS PATIENTS BASED ON RENAL FUNCTION1. Transplantation. 66(8). 1104–1107. 39 indexed citations
6.
McGory, R., Stephen H. Caldwell, Stephen J. Bickston, et al.. (1997). RETRANSPLANTATION OF PATIENTS WITH SEVERE POSTTRANSPLANT HEPATITIS B IN THE FIRST ALLOGRAFT. Transplantation. 64(3). 410–414. 21 indexed citations
7.
McGory, R., Michael B. Ishitani, Walter Oliveira, et al.. (1996). IMPROVED OUTCOME OF ORTHOTOPIC LIVER TRANSPLANTATION FOR CHRONIC HEPATITIS B CIRRHOSIS WITH AGGRESSIVE PASSIVE IMMUNIZATION. Transplantation. 61(9). 1358–1364. 216 indexed citations
8.
McGory, R., et al.. (1996). Liver transplantation for hepatitis B cirrhosis: clinical sequela of passive immunization. Clinical Transplantation. 10(6pt2). 668–675. 23 indexed citations
9.
McGory, R., et al.. (1996). Prostaglandin E1 administration following orthotopic liver transplantation: A randomized prospective multicenter trial. Gastroenterology. 111(3). 710–715. 51 indexed citations
10.
McGory, R., et al.. (1996). Successful retransplantation for recurrent posttransplant hepatitis B virus infection in the primary allograft.. PubMed. 28(3). 1714–6. 1 indexed citations
11.
McGory, R., et al.. (1996). Hepatitis B immune globulin dose requirements following orthotopic liver transplantation for chronic hepatitis B cirrhosis.. PubMed. 28(3). 1687–8. 3 indexed citations
12.
Cofer, Joseph B., Timothy L. Pruett, R. McGory, et al.. (1996). Prostaglandin E1 administration following orthotopic liver transplantation: a randomized prospective multicenter trial. European Journal of Gastroenterology & Hepatology. 8(12). 1243–1243. 2 indexed citations
13.
Matzke, Gary R., R. McGory, C E Halstenson, & W. F. Keane. (1984). Pharmacokinetics of vancomycin in patients with various degrees of renal function. Antimicrobial Agents and Chemotherapy. 25(4). 433–437. 279 indexed citations
14.
Jacobi, Judith, et al.. (1983). Hemodialysis clearance of total and unbound lidocaine.. PubMed. 2(1). 54–7. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026